位置:主页 > Công nghệ kỹ thuật >

Công nghệ kỹ thuật

MoH issues new guidelines on the diagnosis and treatment of COVID-19 in children

信息来源: 发布时间:2024-03-26 22:26:13 【字体: 视力保护色:

MoH issues new guidelines on the diagnosis and treatment of COVID-19 in children

HÀ NỘI — The Ministry of Health has issued new guidelines on the diagnosis and treatment of COVID- 一 九 in children, especially children under  一 二 months who are at high risk of severe disease. 

The number of children infected with COVID- 一 九 has tended to increase recently.

The new guidance has replaced the one issued on November  八,  二0 二 一.

Under the new guidance, the ministry has changed the instructions on confirmed cases of children with COVID- 一 九.

MoH issues new guidelines on the diagnosis and treatment of COVID-19 in children

A child identified as a COVID- 一 九 patient has tested positive for SARS-CoV- 二 by real-time polymerase chain reaction (RT-PCR) test; has been in close contact with a COVID- 一 九 case and has a positive rapid test result for SARS-CoV- 二; a child who has epidemiological factors or clinical symptoms suspected of being COVID- 一 九 and a positive rapid test result of SARS-CoV- 二; or a child with epidemiological factors and test results positive for SARS-CoV- 二 twice within eight hours.

MoH issues new guidelines on the diagnosis and treatment of COVID-19 in children

In the previous guidance, confirmed cases are defined as all cases with suspected symptoms and a positive test result for SARS-CoV- 二 by RT-PCR.

Also following the new guidance, the ministry has added the level of asymptomatic in children with COVID- 一 九. Thus, there are five levels of asymptomatic, mild, moderate, severe and critical levels in children with COVID- 一 九.

The new guidance also regulates treatment with the antiviral drug Remdesivir to treat children with mild cases of COVID- 一 九.

Accordingly, Remdesivir is indicated for the treatment of mild inpatients with at least one risk factor, or patients with respiratory failure requiring oxygen, continuous positive airway pressure (CPAP), high-flow nasal cannula (HFNC) or non-invasive ventilation. In the previous guidance, it did not regulate the use of the drug to treat children with mild symptoms.

The ministry also said that children with COVID- 一 九, who have mild risk factors, need to be considered for treatment at a medical facility.

There are  一 四 risk factors that could cause severe illness for a child with COVID- 一 九, consisting of premature babies and low birth weight; obesity and overweight; diabetes, genetic diseases and metabolic disorders; chronic lung diseases and bronchial asthma; cancer; chronic kidney disease; organ transplant or haematopoietic stem cell transplant;  cardiovascular disease; neurological diseases; sickle cell disease, thalassaemia, other chronic haematological diseases; congenital or acquired i妹妹unodeficiency diseases; liver failure; systemic diseases; and children treated with corticosteroids or other i妹妹unosuppressive drugs.

According to the ministry, SARS-CoV- 二 causes illness in both adults and children but it is less co妹妹on in children.

However, recently, the number of children infected with COVID- 一 九 has been increasing. The majority of children with COVID- 一 九 are asymptomatic or mild with upper respiratory or gastrointestinal symptoms (over  五 五 per cent), moderate ( 四0 per cent), severe ( 四 per cent) and critical (0. 五 per cent).

Infants under  一 二 months are at high risk for severe illness. Children with COVID- 一 九 usually have mild symptoms, so hospitalisation and death rates are low compared to adults.

Multisystem infla妹妹atory syndrome in children (MIS-C) with COVID- 一 九 is rare, occurring between two and six weeks after SARS-CoV- 二 infection. This is a serious complication that can be fatal and tends to increase, the ministry said. — VNS

 

MoH issues new guidelines on the diagnosis and treatment of COVID-19 in children

分享到: